Palbociclib, an inhibitor of CDK4, induced cell cycle arrest in the G1 phase and inhibited the proliferation, migration, and invasion of chondrosarcoma cells through the CDK4/Rb signaling pathway. Here, RB1 is linked to chondrosarcoma.